BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18575778)

  • 1. Molecular regulation of S100P in human lung adenocarcinomas.
    Rehbein G; Simm A; Hofmann HS; Silber RE; Bartling B
    Int J Mol Med; 2008 Jul; 22(1):69-77. PubMed ID: 18575778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
    Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
    Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcupine expression is associated with the expression of S100P and other cancer-related molecules in non-small cell lung carcinoma.
    Bartling B; Rehbein G; Simm A; Silber RE; Hofmann HS
    Int J Oncol; 2010 Apr; 36(4):1015-21. PubMed ID: 20198348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
    Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
    Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.
    Guo L; Chen S; Jiang H; Huang J; Jin W; Yao S
    Int J Clin Exp Pathol; 2014; 7(5):2102-12. PubMed ID: 24966918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100P: a novel therapeutic target for cancer.
    Arumugam T; Logsdon CD
    Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evidence implicating S100P in prostate cancer progression.
    Basu GD; Azorsa DO; Kiefer JA; Rojas AM; Tuzmen S; Barrett MT; Trent JM; Kallioniemi O; Mousses S
    Int J Cancer; 2008 Jul; 123(2):330-339. PubMed ID: 18452169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
    Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
    Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation and functional implication of S100P in cancer.
    Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
    Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.
    Du M; Wang G; Ismail TM; Gross S; Fernig DG; Barraclough R; Rudland PS
    J Biol Chem; 2012 May; 287(19):15330-44. PubMed ID: 22399300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.
    Bartling B; Hofmann HS; Weigle B; Silber RE; Simm A
    Carcinogenesis; 2005 Feb; 26(2):293-301. PubMed ID: 15539404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.
    Jiang H; Hu H; Lin F; Lim YP; Hua Y; Tong X; Zhang S
    Cancer Invest; 2016 Nov; 34(10):477-488. PubMed ID: 27918216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
    Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
    Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
    Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
    FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose promotes tumor cell proliferation and migration in lung adenocarcinoma via the RAGE‑NOXs pathway.
    Liao YF; Yin S; Chen ZQ; Li F; Zhao B
    Mol Med Rep; 2018 Jun; 17(6):8536-8541. PubMed ID: 29693146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.
    Dowen SE; Crnogorac-Jurcevic T; Gangeswaran R; Hansen M; Eloranta JJ; Bhakta V; Brentnall TA; Lüttges J; Klöppel G; Lemoine NR
    Am J Pathol; 2005 Jan; 166(1):81-92. PubMed ID: 15632002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.